The FDA granted an accelerated approval to AbbVie’s c-Met-directed ADC Emrelis as a new treatment option for adults with locally advanced or metastatic, non-squamous non-small cell lung cancer who’ve previously received systemic therapy. The green light equips AbbVie with a
read moreAdd Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald Trump continues to ramp up pressure on the biopharma industry. On Wednesday, Sanofi said it will invest at least $20
read more
Trial progresses towards topline data expected later in the year More: Herantis Pharma doses final cohort in phase 1b trial of HER-096 for Parkinson’s disease Source: News
read more
FDA recognises KER-0193 as a potential therapy for rare paediatric disease More: Kaerus Bioscience secures orphan drug designation for fragile x syndrome treatment Source: News
read morePresident Donald Trump’s recent executive order on drug prices threatens Roche’s ability to fund the tens of billions of U.S. investment projects the company has planned for the next five years, the company said in a statement. More: Roche to
read moreA new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and more on those who work around the clock to take care of them. More: Genentech pays tribute to moms of
read more© 1994 - 2026 B.M. Pharmaceuticals